CETP inhibitors

Details for Australian Patent Application No. 2006335110 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Sinclair, Peter J.; Lu, Zhijian; Ali, Amjad; Thompson, Christopher F.; Taylor, Gayle E.; Smith, Cameron J.; Chen, Yi-Heng; Dowst, Adrian A.

Agent Spruson & Ferguson

Pub. Number AU-B-2006335110

PCT Pub. Number WO2007/081571

Priority 60/755,251 30.12.05 US

Filing date 29 December 2006

Wipo publication date 19 July 2007

Acceptance publication date 14 April 2011

International Classifications

C07D 263/16 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/081571 Priority application(s): WO2007/081571

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp. Amendments

14 April 2011 Application Accepted

  Published as AU-B-2006335110

11 August 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp. 2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006335111-Inhibitors of checkpoint kinases

2006335109-Cholesteryl ester transfer protein inhibitors